ADV-TK Uses, Dosage, Side Effects and more
ADV-TK is under investigation in clinical trial NCT00638612 (AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)).
| Trade Name | ADV-TK |
| Generic | Aglatimagene besadenovec |
| Aglatimagene besadenovec Other Names | ADV-TK, Aglatimagene besadenovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
